SLC7A11 and neoplasm: This study also provides evidence for the hypothesis that—in addition to their desirable effect on tumor cells—sorafenib and erastin interfere with neuronal function and extracellular homeostasis, which should be taken into account when developing future chemotherapeutics on the basis of xCT inhibitors.